Form 4: ADC Therapeutics Officer Sells Shares for Tax Obligations

ADC Therapeutics' Chief Accounting Officer, Lisa Michelle Kallebo, disposed of 7,140 common shares to cover tax withholding obligations related to vested restricted share units.

Summary

• Lisa Michelle Kallebo, Chief Accounting Officer of ADC Therapeutics SA (ADCT), reported a transaction on December 6, 2025.
• The transaction involved the disposition of 7,140 common shares at a price of $3.29 per share.
• These shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of previously granted restricted share units.
• Following this transaction, Lisa Michelle Kallebo beneficially owns 70,757 common shares directly.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares for tax purposes upon RSU vesting and does not indicate any positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies when restricted stock units vest.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary sale for tax purposes and does not reflect a change in the officer's investment thesis or the company's fundamentals.
• Employees: No direct impact beyond the reporting person's compensation structure.

Key Dates

Recommendation

This Form 4 reports a routine disposition of shares by an officer to satisfy tax withholding obligations related to the vesting of restricted share units. Such transactions are not typically indicative of management's view on the company's future performance or a change in the company's fundamentals, thus a 'hold' recommendation is appropriate as this event does not alter the investment thesis.

Keywords

ADCT, Form 4, Insider Transaction, Share Disposition, Tax Withholding, Restricted Share Units, Corporate Officer